RDCD Stock Overview
Operates in online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Redcare Pharmacy NV Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €155.10 |
| 52 Week High | €163.15 |
| 52 Week Low | €117.40 |
| Beta | 0.99 |
| 11 Month Change | 8.31% |
| 3 Month Change | 16.88% |
| 1 Year Change | 26.41% |
| 33 Year Change | 4.30% |
| 5 Year Change | 318.06% |
| Change since IPO | 297.69% |
Recent News & Updates
Recent updates
Shareholder Returns
| RDCD | GB Consumer Retailing | GB Market | |
|---|---|---|---|
| 7D | -4.9% | 0.1% | -0.3% |
| 1Y | 26.4% | 13.1% | 6.1% |
Return vs Industry: RDCD exceeded the UK Consumer Retailing industry which returned 13.1% over the past year.
Return vs Market: RDCD exceeded the UK Market which returned 6.1% over the past year.
Price Volatility
| RDCD volatility | |
|---|---|
| RDCD Average Weekly Movement | n/a |
| Consumer Retailing Industry Average Movement | 3.2% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: RDCD's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine RDCD's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 1,900 | Olaf Heinrich | www.redcare-pharmacy.com |
Redcare Pharmacy NV operates in online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It provides prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023.
Redcare Pharmacy NV Fundamentals Summary
| RDCD fundamental statistics | |
|---|---|
| Market cap | €3.01b |
| Earnings (TTM) | -€24.56m |
| Revenue (TTM) | €2.23b |
1.4x
P/S Ratio-122.6x
P/E RatioIs RDCD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RDCD income statement (TTM) | |
|---|---|
| Revenue | €2.23b |
| Cost of Revenue | €1.71b |
| Gross Profit | €516.65m |
| Other Expenses | €541.21m |
| Earnings | -€24.56m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.21 |
| Gross Margin | 23.20% |
| Net Profit Margin | -1.10% |
| Debt/Equity Ratio | 45.6% |
How did RDCD perform over the long term?
See historical performance and comparison